Buy Edge Therapeutics Stock | EDGE Stock Price & Latest News | Public
EDGE

Edge Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About EDGE

    PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS010...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.13
    -0.26
    -0.39
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.19

    Actual EPS
    Q4 2020

    Stats

    Market Cap$43,41M
    Volume3k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.98
    1 Year Low$0.62
    Open$1.95
    High$2.02
    Low$1.94

    Buy any stock with any amount of money.

    Download the App
    Download the app